Cite
Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity.
MLA
Li, Ruitong, et al. “Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity.” Cancers, vol. 14, no. 7, Apr. 2022, p. 1811. EBSCOhost, https://doi.org/10.3390/cancers14071811.
APA
Li, R., Ugai, T., Xu, L., Zucker, D., Ogino, S., & Wang, M. (2022). Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity. Cancers, 14(7), 1811. https://doi.org/10.3390/cancers14071811
Chicago
Li, Ruitong, Tomotaka Ugai, Lantian Xu, David Zucker, Shuji Ogino, and Molin Wang. 2022. “Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity.” Cancers 14 (7): 1811. doi:10.3390/cancers14071811.